Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Venous Thromboembolism (VTE)137.67M94.41%
Emerging Therapies8.15M5.59%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States469.86M95.19%
International23.77M4.81%